Publications by authors named "Daniel Lamb"

Claim this Profile
D
Discovery of PF-07054894, a Potent Squaramide-Based CCR6 Antagonist Displaying High CXCR2 Selectivity.
Mark E Schnute, Huixian Wu, John I Trujillo, Wei Li, David Jonathan Wasilko, Daniel Lamb

J Med Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of mycotic common iliac aneurysm in a patient with ventriculoperitoneal shunt.
Joseph DiBello, Justin Smith, Michael Sheehan, Daniel Lamb, Joseph McShannic

J Vasc Surg Cases Innov Tech· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists.
Brian S Gerstenberger, Ray Unwalla, Kathleen A Farley, Philippe Nuhant, Vincent M Lombardo, Daniel Lamb

J Med Chem· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis for CCR6 modulation by allosteric antagonists.
David Jonathan Wasilko, Brian S Gerstenberger, Kathleen A Farley, Wei Li, Jennifer Alley, Daniel Lamb

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the role of transthoracic echocardiography in hospitalised patients with COVID-19 infection.
Aswin Babu, Zhaoyi Meng, Nadia Eden, Daniel Lamb, Jan Nouza

Open Heart· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real time monitoring of membrane GPCR reconstitution by plasmon waveguide resonance: on the role of lipids.
Pierre Calmet, Monica De Maria, Etienne Harté, Daniel Lamb, Maria Serrano-Vega

Sci Rep· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extra-helical binding site of a glucagon receptor antagonist.
Ali Jazayeri, Andrew S Doré, Daniel Lamb, Harini Krishnamurthy, Stacey M Southall

Nature· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Charge-surrounded pockets and electrostatic interactions with small ions modulate the activity of retroviral fusion proteins.
Daniel Lamb, Alexander W Schüttelkopf, Daan M F van Aalten, David W Brighty

PLoS Pathog· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.
Daniel Lamb, Antonis Mirsaliotis, Sharon M Kelly, David W Brighty

J Biol Chem· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly specific inhibition of leukaemia virus membrane fusion by interaction of peptide antagonists with a conserved region of the coiled coil of envelope.
Daniel Lamb, Alexander W Schüttelkopf, Daan M F van Aalten, David W Brighty

Retrovirology· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonhelical leash and alpha-helical structures determine the potency of a peptide antagonist of human T-cell leukemia virus entry.
Antonis Mirsaliotis, Daniel Lamb, David W Brighty

J Virol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance to neutralization by antibodies targeting the coiled coil of fusion-active envelope is a common feature of retroviruses.
Antonis Mirsaliotis, Kulpash Nurkiyanova, Daniel Lamb, Chien-Wen S Kuo, David W Brighty

J Biol Chem· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conformation-specific antibodies targeting the trimer-of-hairpins motif of the human T-cell leukemia virus type 1 transmembrane glycoprotein recognize the viral envelope but fail to neutralize viral entry.
Antonis Mirsaliotis, Kulpash Nurkiyanova, Daniel Lamb, Jenny M Woof, David W Brighty

J Virol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An antibody that blocks human T-cell leukemia virus type 1 six-helix-bundle formation in vitro identified by a novel assay for inhibitors of envelope function.
Antonis Mirsaliotis, Kulpash Nurkiyanova, Daniel Lamb, Chien-Wen S Kuo, David W Brighty

J Gen Virol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis